In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range

Ann Intern Med. 2014 Mar 18;160(6):JC10. doi: 10.7326/0003-4819-160-6-201403180-02010.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Sodium-Glucose Transporter 2 / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2